These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
381 related articles for article (PubMed ID: 26157753)
1. Predictive factors of contrast-enhanced ultrasonography for the response to transarterial chemoembolization in hepatocellular carcinoma. Park KH; Kwon SH; Lee YS; Jeong SW; Jang JY; Lee SH; Kim SG; Cha SW; Kim YS; Cho YD; Kim HS; Kim BS; Kim YJ Clin Mol Hepatol; 2015 Jun; 21(2):158-64. PubMed ID: 26157753 [TBL] [Abstract][Full Text] [Related]
2. The usefulness of contrast-enhanced ultrasonography in the early detection of hepatocellular carcinoma viability after transarterial chemoembolization: pilot study. Cho YZ; Park SY; Choi EH; Baik SK; Kwon SO; Kim YJ; Cha SH; Kim MY Clin Mol Hepatol; 2015 Jun; 21(2):165-74. PubMed ID: 26157754 [TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced ultrasonography of hepatocellular carcinoma after chemoembolisation using drug-eluting beads: a pilot study focused on sustained tumor necrosis. Moschouris H; Malagari K; Papadaki MG; Kornezos I; Matsaidonis D Cardiovasc Intervent Radiol; 2010 Oct; 33(5):1022-7. PubMed ID: 20101403 [TBL] [Abstract][Full Text] [Related]
4. Comparison of volume perfusion computed tomography and contrast-enhanced ultrasound for assessment of therapeutic effect of transarterial chemoembolization in patients with hepatocellular carcinoma: a preliminary report. Kaufmann S; Schulze M; Spira D; Horger M Acta Radiol; 2016 Jan; 57(1):8-12. PubMed ID: 25585848 [TBL] [Abstract][Full Text] [Related]
5. Transarterial Chemoembolization of HCC with Radiopaque Microspheres: Evaluation with Computed Tomography and the Complementary Role of Contrast-Enhanced Ultrasonography. Moschouris H; Malagari K; Dimakis A; Kiakidis T; Anagnostopoulou A Cardiovasc Intervent Radiol; 2020 Jul; 43(7):1075-1083. PubMed ID: 32394087 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the microcirculation of hepatocellular carcinomas using contrast-enhanced ultrasound with intraarterial and intravenous contrast application during transarterial chemoembolization with drug-eluting beads (DEB-TACE): preliminary data. Uller W; Wiggermann P; Gössmann H; Klebl F; Salzberger B; Stroszczynski C; Jung EM Clin Hemorheol Microcirc; 2011; 49(1-4):55-66. PubMed ID: 22214678 [TBL] [Abstract][Full Text] [Related]
7. Imaging of intrahepatic progression of hepatocellular carcinoma post transarterial chemoembolization. A long-term, prospective evaluation of contrast-enhanced ultrasonography (CEUS). Moschouris H; Kalokairinou-Motogna M; Vrakas S; Papadatou A; Karagiannis E; Kiltenis M; Kladis-Kalentzis K; Marmaridou K; Papadogeorgopoulos N; Malagari K Med Ultrason; 2017 Apr; 19(2):134-142. PubMed ID: 28440346 [TBL] [Abstract][Full Text] [Related]
8. Contrast-enhanced ultrasonography with intraarterial administration of SonoVue for guidance of transarterial chemoembolization: an initial experience. Moschouris H; Malagari K; Kalokairinou M; Stamatiou K; Marinis A; Papadaki MG Med Ultrason; 2011 Dec; 13(4):296-301. PubMed ID: 22132402 [TBL] [Abstract][Full Text] [Related]
9. Intraarterial contrast-enhanced ultrasound to predict the short-term tumour response of hepatocellular carcinoma to Transarterial chemoembolization with Lipiodol. Bo J; Peng H; LianHua Z; Xiang F; YuKun L BMC Cancer; 2021 Nov; 21(1):1171. PubMed ID: 34727882 [TBL] [Abstract][Full Text] [Related]
10. Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary results. Ross CJ; Rennert J; Schacherer D; Girlich C; Hoffstetter P; Heiss P; Jung W; Feuerbach S; Zorger N; Jung EM Clin Hemorheol Microcirc; 2010; 46(2-3):101-15. PubMed ID: 21135486 [TBL] [Abstract][Full Text] [Related]
11. Intra-arterial contrast-enhanced ultrasound (IA CEUS) for localization of hepatocellular carcinoma (HCC) supply during transarterial chemoembolization (TACE): a case series. Lekht I; Nayyar M; Luu B; Guichet PL; Ho J; Ter-Oganesyan R; Katz M; Gulati M Abdom Radiol (NY); 2017 May; 42(5):1400-1407. PubMed ID: 28008454 [TBL] [Abstract][Full Text] [Related]
12. mRECIST criteria and contrast-enhanced US for the assessment of the response of hepatocellular carcinoma to transarterial chemoembolization. Moschouris H; Malagari K; Papadaki MG; Kornezos I; Stamatiou K; Anagnostopoulos A; Chatzimichael K; Kelekis N Diagn Interv Radiol; 2014; 20(2):136-42. PubMed ID: 24317334 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of Texture Analysis Parameter for Response Prediction in Patients with Hepatocellular Carcinoma Undergoing Drug-eluting Bead Transarterial Chemoembolization (DEB-TACE) Using Biphasic Contrast-enhanced CT Image Data: Correlation with Liver Perfusion CT. Kloth C; Thaiss WM; Kärgel R; Grimmer R; Fritz J; Ioanoviciu SD; Ketelsen D; Nikolaou K; Horger M Acad Radiol; 2017 Nov; 24(11):1352-1363. PubMed ID: 28652049 [TBL] [Abstract][Full Text] [Related]
14. Transarterial chemoembolization for hepatocellular carcinoma with a new generation of beads: clinical-radiological outcomes and safety profile. Spreafico C; Cascella T; Facciorusso A; Sposito C; Rodolfo L; Morosi C; Civelli EM; Vaiani M; Bhoori S; Pellegrinelli A; Marchianò A; Mazzaferro V Cardiovasc Intervent Radiol; 2015 Feb; 38(1):129-34. PubMed ID: 24870698 [TBL] [Abstract][Full Text] [Related]
15. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization. Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of tumor response to intra-arterial chemoembolization of hepatocellular carcinoma: Comparison of contrast-enhanced ultrasound with multiphase computed tomography. Paul SB; Dhamija E; Gamanagatti SR; Sreenivas V; Yadav DP; Jain S; Shalimar ; Acharya SK Diagn Interv Imaging; 2017 Mar; 98(3):253-260. PubMed ID: 27692674 [TBL] [Abstract][Full Text] [Related]
17. Comparison of contrast-enhanced ultrasound and contrast-enhanced computed tomography in evaluating the treatment response to transcatheter arterial chemoembolization of hepatocellular carcinoma using modified RECIST. Liu M; Lin MX; Lu MD; Xu ZF; Zheng KG; Wang W; Kuang M; Zhuang WQ; Xie XY Eur Radiol; 2015 Aug; 25(8):2502-11. PubMed ID: 25702094 [TBL] [Abstract][Full Text] [Related]
18. Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center. Vogl TJ; Trapp M; Schroeder H; Mack M; Schuster A; Schmitt J; Neuhaus P; Felix R Radiology; 2000 Feb; 214(2):349-57. PubMed ID: 10671580 [TBL] [Abstract][Full Text] [Related]
19. Degradable starch microspheres transarterial chemoembolization (DSMs-TACE) in patients with unresectable hepatocellular carcinoma (HCC): long-term results from a single-center 137-patient cohort prospective study. Orlacchio A; Chegai F; Roma S; Merolla S; Bosa A; Francioso S Radiol Med; 2020 Jan; 125(1):98-106. PubMed ID: 31583558 [TBL] [Abstract][Full Text] [Related]
20. Transcatheter arterial chemoembolization with doxorubicin-eluting superabsorbent polymer microspheres in the treatment of hepatocellular carcinoma: midterm follow-up. Dekervel J; van Malenstein H; Vandecaveye V; Nevens F; van Pelt J; Heye S; Laleman W; Van Steenbergen W; Vaninbroukx J; Verslype C; Maleux G J Vasc Interv Radiol; 2014 Feb; 25(2):248-55.e1. PubMed ID: 24295569 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]